Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqGM:BRCB
NasdaqGM:BRCBHospitality

Assessing Black Rock Coffee Bar (BRCB): Is Current Valuation Supported by Recent Steady Performance?

If you’ve been tracking Black Rock Coffee Bar (BRCB), you might have noticed the company quietly inching past headlines lately. While there hasn't been a single seismic event to jolt investors, the recent trading patterns have turned some heads. On the surface, the moves are subtle, with no bombshell announcements or abrupt surges. Still, even small shifts can spark bigger questions about where the value lies and what the market is forecasting for this growing player in the coffee...
TSXV:APGO
TSXV:APGOMetals and Mining

Apollo Silver (TSXV:APGO) Valuation in Focus After Expanded Calico Resource Adds Critical Minerals

If you are watching Apollo Silver (TSXV:APGO), the company’s latest mineral resource update for its Calico Project deserves your attention. For the first time, Apollo included barite and zinc, both classified as critical minerals in the United States, alongside its silver and gold estimates. This broadens the project’s scope and, potentially, shifts market expectations. This expanded resource base could open up new developmental and economic possibilities, just as the company prepares for an...
NasdaqGS:CCCC
NasdaqGS:CCCCBiotechs

Has C4 Therapeutics’ (CCCC) Biogen Partnership Become a Defining Test of Its Collaborative Model?

Biogen recently announced that the U.S. FDA accepted its investigational new drug application for BIIB142, an IRAK4 degrader developed in collaboration with C4 Therapeutics, for the treatment of autoimmune diseases. This regulatory milestone highlights C4 Therapeutics’ expertise in targeted protein degradation and the momentum in its partnerships, which are advancing clinical-stage candidates. We'll explore how Biogen's progress with BIIB142 influences C4 Therapeutics' investment narrative...
BIT:SL
BIT:SLLeisure

Sanlorenzo (BIT:SL) Is Up 5.5% After Reporting Higher Half-Year Profits—Has the Bull Case Changed?

Sanlorenzo S.p.A. announced its earnings for the half year ended June 30, 2025, reporting net income of €46.63 million compared to €43.58 million a year earlier. This release highlighted a year-over-year increase in profits, reinforcing ongoing user interest in Sanlorenzo’s underlying financial performance. We’ll examine how Sanlorenzo’s profit growth shapes its investment narrative and the outlook for sustained earnings and market expansion. Rare earth metals are the new gold rush. Find out...
BIT:CMB
BIT:CMBElectrical

Assessing Cembre (BIT:CMB) Valuation Following Strong Half-Year Earnings Growth

The latest earnings announcement from Cembre (BIT:CMB) has definitely caught the market’s attention. The company just reported half-year results showing increased sales, revenue, and net income compared to the same period last year, signaling steady growth and solid execution. For shareholders and prospective investors alike, strong earnings can often shift the risk-reward discussion. This serves as a reminder to revisit what the business is worth and how future growth might be reflected in...
NasdaqCM:MBOT
NasdaqCM:MBOTMedical Equipment

Microbot Medical (MBOT) Is Up After FDA Clears LIBERTY System and $92 Million Funding Plan—What’s Next?

Microbot Medical recently announced that the FDA has granted 510(k) clearance for its LIBERTY® System, making it the first single-use, remotely operated robotic device approved for peripheral endovascular procedures in the U.S., and revealed plans to raise up to US$92.2 million in gross proceeds through the exercise of preferred investment options to support commercialization and further product development. This dual milestone both enables commercial launch of a novel medical technology and...
NasdaqGS:ARCC
NasdaqGS:ARCCCapital Markets

Ares Capital (ARCC): Evaluating Valuation After Stock Drop and Lower Earnings Outlook

It has been an interesting week for Ares Capital (ARCC) as the company posted a sharp decline in its stock price, dropping over 4% at a time when both the S&P 500 and Nasdaq posted gains. This pullback happened just days after Ares Capital announced the issuance of $650 million in 5.1% notes due 2031, signaling a significant move in its capital structure. The borrowing is intended to repay outstanding debt and leave room for future investments, but the combination of a new bond offering and a...
NYSE:SQNS
NYSE:SQNSSemiconductor

Sequans Communications (NYSE:SQNS) Valuation Spotlight as 1-for-10 Stock Split Approaches

Sequans Communications (NYSE:SQNS) is making waves among investors after announcing a 1-for-10 stock split set for September 17, 2025. If you are assessing your portfolio or considering an entry, this event may have just put Sequans Communications onto your radar. While a stock split does not change the company’s fundamentals, it can influence investor sentiment and often brings about shifts in trading behavior as the share count and price per share are realigned. Stepping back from the...
BIT:SOL
BIT:SOLChemicals

SOL (BIT:SOL) Valuation in Focus After Strong Half-Year Earnings Growth

SOL (BIT:SOL) caught investors’ eyes this week with its half-year earnings announcement, revealing across-the-board improvements in sales, revenue, net income, and earnings per share when compared to last year’s figures. Delivering sales of €874.08 million and net income of €83.52 million points to a business that continues to expand its financial footprint. For shareholders deciding their next move, these results may serve as a signal on whether to stay the course or take a fresh look at...
XTRA:EVD
XTRA:EVDEntertainment

Will CTS Eventim (XTRA:EVD) Sustain Its Transformation Momentum as CFO Hohrein Prepares to Depart?

CTS Eventim AG & Co. KGaA recently announced that Chief Financial Officer Holger Hohrein will leave the Executive Board at the end of December 2025, with both parties mutually agreeing not to extend his contract and a successor to be named later. Hohrein’s tenure was marked by significant transformation initiatives, including finance process modernization, digitalization, and international expansion, shaping the company’s evolution during an intense growth period. We’ll explore how the...
NasdaqGS:HAIN
NasdaqGS:HAINFood

Hain Celestial Group (HAIN) Is Down 22.0% After Heavy Quarterly Losses and Major Asset Impairments - What's Changed

The Hain Celestial Group, Inc. recently reported its fourth-quarter results for the period ended June 30, 2025, posting sales of US$363.35 million, a sharp decline from US$418.8 million a year earlier, and a net loss of US$272.62 million compared to US$2.94 million the prior year. Significant impairments, including US$227.36 million in goodwill and US$24.91 million in intangibles and long-lived assets, highlight mounting financial pressures and operational headwinds facing the company. We'll...
NYSEAM:TGEN
NYSEAM:TGENBuilding

Tecogen (TGEN) Is Up 5.7% After Clearing All Debt Early Will Its Financial Flexibility Pay Off?

On September 2, 2025, Tecogen's Audit Committee approved the full prepayment of two promissory notes totaling US$1 million plus accrued interest to director John N. Hatsopoulos, settling the company's debt ahead of schedule. This early repayment eliminated all outstanding company debt and saved Tecogen approximately US$46,159 in future interest expenses that would have otherwise accrued through to maturity. We'll explore how the complete elimination of debt could shape Tecogen's investment...
NasdaqGS:CBRL
NasdaqGS:CBRLHospitality

The Bull Case For Cracker Barrel (CBRL) Could Change Following Halt to Modern Decor Rollout—Learn Why

Cracker Barrel Old Country Store released its fourth-quarter fiscal 2025 results after the market closed, following a decision to halt its planned restaurant decor modernization after backlash over logo and design changes. This move highlights the strong influence of customer sentiment on Cracker Barrel's transformation initiatives as it balances operational innovation with preserving brand identity. We'll explore how the halt to restaurant decor changes might influence Cracker Barrel's...
NYSE:TTI
NYSE:TTIEnergy Services

3 Promising Penny Stocks With Market Caps Under $700M

As the Dow Jones Industrial Average gains traction while the Nasdaq and S&P 500 experience slight declines, investors are keenly watching for signals from the Federal Reserve's anticipated interest rate cut. In such a fluctuating market, identifying promising investments can be challenging, yet opportunities abound for those who look beyond established giants. Though often seen as relics of past trading days, penny stocks continue to offer intriguing possibilities; when backed by solid...
AIM:BOOM
AIM:BOOMInteractive Media and Services

UK Penny Stocks To Watch With Market Caps Under £200M

The UK market has recently experienced volatility, with the FTSE 100 index closing lower amid concerns over weak trade data from China and its impact on global demand. In such a climate, investors may seek opportunities in smaller or less-established companies that can offer potential value. Penny stocks, though an older term, highlight these types of companies and can still present intriguing opportunities when backed by strong financials.